Debut Plus

₹449.85

▼ -3.99 -0.88%

As of 23 Oct 2026 · delayed

NSE Listed

Cohance Lifesciences Ltd. (COHANCE)

Volume: 5,73,702Avg Vol 1W: 5,66,764Avg Vol 1M: 7,63,318.552W Range:₹266.7₹903.4
NSE BSE www.suvenpharm.com AI Report
Key Ratios
Checked 13h ago
Market Cap₹17,211 Cr
Current Price₹449.85
Previous Close₹453.84
High / Low (52w)₹903.4 / ₹266.7
Volume5,73,702
Avg Vol (1W)5,66,764
Avg Vol (1M)7,63,318.5
Stock P/E108.7
Book Value₹90.95
Dividend Yield—
ROE12.5%
ROA—
Revenue (TTM)₹1,256 Cr
Revenue Growth—
Profit Margin—
Total Debt₹6 Cr
Shares Outstanding—
Face Value₹1
EPS (TTM)₹10.67
P/B12.75
Debt / Equity0.04
50 DMA₹450.86
200 DMA₹408.9
Day change-0.88%
Price Chart
₹449.85▼ 47.10% · 1Y
₹860₹2804.8Cr
2025-10-27
2026-10-23

20-day avg volume: 7.6L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 17% YoY.
  • Stock trades at a high P/E of 109.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹604 Cr₹676 Cr₹840 Cr₹549 Cr₹556 Cr₹545 Cr₹619 Cr₹422 Cr
EBITDA₹184 Cr₹215 Cr₹187 Cr₹81 Cr₹93 Cr₹55 Cr₹46 Cr₹-36 Cr
Net Profit₹138 Cr₹153 Cr₹120 Cr₹49 Cr₹74 Cr₹37 Cr₹20 Cr₹-24 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹2,678 Cr₹769 Cr₹484 Cr₹498 Cr₹482 Cr₹568 Cr₹2,303 Cr₹360 Cr
EBITDA₹699 Cr₹188 Cr₹86 Cr₹126 Cr₹76 Cr₹78 Cr₹274 Cr₹4 Cr
Net Profit₹487 Cr₹123 Cr₹53 Cr₹94 Cr₹47 Cr₹35 Cr₹179 Cr₹1 Cr
EPS12.68—————4.68—
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹783 Cr₹1,173 Cr₹1,474 Cr₹1,830 Cr₹1,966 Cr₹2,254 Cr₹5,481 Cr₹5,730 Cr
Total Liabilities₹193 Cr₹328 Cr₹294 Cr₹302 Cr₹231 Cr₹203 Cr₹1,688 Cr₹1,696 Cr
Equity₹590 Cr₹845 Cr₹1,181 Cr₹1,527 Cr₹1,735 Cr₹2,051 Cr₹3,793 Cr₹4,034 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹83 Cr₹493 Cr₹492 Cr₹514 Cr₹603 Cr₹468 Cr₹849 Cr₹436 Cr
Investing₹-65 Cr₹-413 Cr₹-311 Cr₹-136 Cr₹-195 Cr₹-362 Cr₹-390 Cr₹-255 Cr
Financing₹26 Cr₹7 Cr₹-76 Cr₹-156 Cr₹-242 Cr₹-14 Cr₹-327 Cr₹-165 Cr
Free Cash Flow₹83 Cr₹493 Cr₹492 Cr₹514 Cr₹603 Cr₹468 Cr₹849 Cr₹436 Cr
Shareholding
Promoter 57.48% Institutions 26.57% Public 15.95%
Efficiency & Working Capital
ROCE5.5%
Interest Coverage6.6
Dividend Payout—
Debtor Days110 d
Inventory Days90 d
Payable Days46 d
Cash Conversion Cycle154 d
Working Capital Days200 d
Shareholding Details

As of 2026-09-30

Promoter57.5%
FII7.7%
DII18.9%
Institutions26.6%
Public16%
Promoter Pledge94.6%
No. of Shareholders93,846
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2024Sept 2024Dec 2024Mar 2025May 2025May 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters50.1%50.1%50.1%50.1%66.4%66.4%66.4%57.5%57.5%57.5%57.5%57.5%
FIIs9.8%10.7%10.8%11%7.4%7.4%7.2%6.5%6%5.6%6.5%7.7%
DIIs17.4%16.9%16.7%16.6%11%11%11.4%20.8%21.6%21.8%20.1%18.9%
Public22.7%22.3%22.4%22.2%15.2%15.2%15%15.2%14.9%15.1%15.9%16%
Promoter Pledge0%0%0%0%0%0%100%100%100%100%94.6%94.6%
No. of Shareholders65,77769,33784,21086,32588,65888,65880,91075,28481,87785,23099,14993,846
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Behryanda LimitedShareholding of Promoter and Promoter Group33.3%12.75 Cr
Jusmiral Holdings LimitedShareholding of Promoter and Promoter Group24.2%9.24 Cr
Jasub Property Holdings LlpPublic Shareholding3.8%1.47 Cr
Sbi Mnc FundPublic Shareholding3.7%1.43 Cr
Icici Prudential Healthcare FundPublic Shareholding3.7%1.41 Cr
Dsp Flexi Cap FundPublic Shareholding2.9%1.11 Cr
Jasti Property And Equity Holdings Private LimitedPublic Shareholding2.5%96,16,009
Amansa Holdings Private LimitedPublic Shareholding2.2%83,35,592
Hdfc Trustee Company Limited - Hdfc Tax SaverfundPublic Shareholding2.2%82,57,896
Sbi Life Insurance Co. LtdPublic Shareholding1.8%66,99,604
Invesco India Contra FundPublic Shareholding1.6%61,57,314
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Behryanda Limited12.75 Cr100%2026-09-30
Jusmiral Holdings Limited8.04 Cr87.1%2026-09-30
Board of Directors
NameDesignationYear
Umang VohraChairman & Group CEO2026
Shweta JalanNon Executive Director2026
Pankaj PatwariNon Executive Director2026
Vinod PadikkalNon-Exec & Non-Independent Dir2026
Matangi GowrishankarIndependent Non Exe. Director2026
Vinod RaoIndependent Non Exe. Director2026
K G AnanthakrishnanIndependent Non Exe. Director2026
U B Pravin RaoIndependent Non Exe. Director2026
Jaishankar KrishnanIndependent Non Exe. Director2026
S. K. MishraCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Manufacturing of Bulk Drugs & Inter₹0 Cr—
Segments — Geography
RegionRevenueShare
USA₹495 Cr24.7%
Europe₹712 Cr35.6%
India₹308 Cr15.4%
Rest of the world₹488 Cr24.4%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹13,5343838
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-05Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202616600220188
20261630000163
2026200002
Insider / Designated-Person Trades

1 recent disclosure(s)

Jusmiral Holdings LimitedDisposal · 3,41,48,000
Substantial Acquisitions (SAST)

4 disclosure(s)

Market07/08/2026 · 28,99,996
Inter-se Transfer23/02/2026 · 77,00,000
Inter-se Transfer18/02/2026 · 70,00,000
Market18/02/2026 · 78,76,948
Company Information
Incorporated2018
ChairmanUmang Vohra
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]
🌐 www.suvenpharm.com ↗

📍 8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5, Hyderabad, Telangana, 500034

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Coal India Ltd.Coastal Corporation Ltd.Cochin Shipyard LimitedJohn Cockerill India Ltd.Coffee Day Enterprise Ltd.Coforge LimitedColab Platforms LimitedColgate-Palmolive (India) Ltd.Comfort Intech Ltd.Committed Cargo Care Ltd.Competent Automobiles Company Ltd.Compuage Infocom Ltd.All “C” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search